OBESITY AND COVID-19: A FORGOTTEN RELATIONSHIP

Descargar Publicación
La FDA otorga la designación de medicamento huérfano para el tratamiento del síndrome de Prader-Willi We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity.